Muromachi Chemicals
4885.TPharmaceutical
In English · 1
Mon, Apr 27 · JST1 filing
17:025% STAKEMuromachi Chemicals · Tetsuro Murayama · 14.89% → 10.01%−4.88ppAll EDINET filings · 42
| Filed | Document | Source |
|---|---|---|
| 2026-09-01 | Material event report | S100YZT8 |
| 2026-08-25 | Internal control report | S100YYCD |
| 2026-08-25 | CEO/CFO certification | S100YYCA |
| 2026-08-25 | Annual report | S100YYBG |
| 2026-04-27 | Large shareholding report | S100Y10Z |
| 2026-01-14 | CEO/CFO certification | S100XFRC |
| 2026-01-14 | Half-year report | S100XFQT |
| 2025-09-01 | Material event report | S100WMD3 |
| 2025-08-26 | Internal control report | S100WL9J |
| 2025-08-26 | CEO/CFO certification | S100WL9I |
| 2025-08-26 | Annual report | S100WL9D |
| 2025-01-14 | CEO/CFO certification | S100V2KA |
| 2025-01-14 | Half-year report | S100V2K6 |
| 2024-09-04 | Material event report | S100UBKM |
| 2024-08-28 | Internal control report | S100UA7F |
| 2024-08-28 | Annual report | S100UA72 |
| 2024-08-28 | CEO/CFO certification | S100UA7D |
| 2024-04-12 | Quarterly report | S100T9HF |
| 2024-04-12 | CEO/CFO certification | S100T9HX |
| 2024-01-12 | Quarterly report | S100SLIK |
| 2024-01-12 | CEO/CFO certification | S100SLIS |
| 2023-10-13 | CEO/CFO certification | S100S0P6 |
| 2023-10-13 | Quarterly report | S100S0P0 |
| 2023-08-25 | Internal control report | S100RQQP |
| 2023-08-25 | CEO/CFO certification | S100RQQM |
| 2023-08-25 | Annual report | S100RQQ8 |
| 2023-06-22 | Large shareholding report | S100R0GF |
| 2023-04-14 | Quarterly report | S100QLE5 |
| 2023-02-03 | Large shareholding report | S100Q28U |
| 2023-01-13 | Quarterly report | S100PYKH |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 5 financial reports not structured yet.